137 related articles for article (PubMed ID: 36715115)
1. RBM15 silencing promotes ferroptosis by regulating the TGF-β/Smad2 pathway in lung cancer.
Feng J; Li Y; He F; Zhang F
Environ Toxicol; 2023 Mar; 38(4):950-961. PubMed ID: 36715115
[TBL] [Abstract][Full Text] [Related]
2. The TGF-β/Smad
Yu ZL; Liu J; Ning ZK; Tian HK; Wu X; Huang YF; Wu ZC; Zong Z; Zhou TC
Mol Carcinog; 2023 Feb; 62(2):261-276. PubMed ID: 36345938
[TBL] [Abstract][Full Text] [Related]
3. FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma.
Li X; Liu J
BMC Cancer; 2023 Feb; 23(1):179. PubMed ID: 36814203
[TBL] [Abstract][Full Text] [Related]
4. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
Zhang C; Gu L; Xiao J; Jin F
BMC Cancer; 2023 Jul; 23(1):684. PubMed ID: 37474926
[TBL] [Abstract][Full Text] [Related]
6. TRAIL predisposes non-small cell lung cancer to ferroptosis by regulating ASK-1/JNK1 pathway.
Liu X; Deng H; Huang M; Zhou W; Yang Y
Discov Oncol; 2024 Feb; 15(1):45. PubMed ID: 38383815
[TBL] [Abstract][Full Text] [Related]
7. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling.
Xia YZ; Shan GF; Yang H; Zha J; Wang L; Chen JM; Zhang XS
Chem Biol Interact; 2021 Apr; 339():109424. PubMed ID: 33617803
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis.
Zhou Q; Wang X; Zhang Y; Wang L; Chen Z
BMC Oral Health; 2022 Nov; 22(1):478. PubMed ID: 36352396
[TBL] [Abstract][Full Text] [Related]
9. KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma.
Dai Z; Huang Q; Huang X; Zhu C; Zahid KR; Liu T; Li Q; Wu C; Peng M; Xiao X; Raza U; Yu N; Zeng T
Mol Carcinog; 2023 Mar; 62(3):369-384. PubMed ID: 36468848
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.
Cai H; Guo F; Wen S; Jin X; Wu H; Ren D
J Exp Clin Cancer Res; 2022 Feb; 41(1):73. PubMed ID: 35193647
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of ferroptosis-related genes in lipopolysaccharide-induced acute lung injury.
Wang S; Song Y; Xu F; Liu H; Shen Y; Hu L; Fu Y; Zhu L
Cell Signal; 2023 Aug; 108():110698. PubMed ID: 37149072
[TBL] [Abstract][Full Text] [Related]
12. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanism of RNA binding motif protein 15-mediated N
Chen J
Environ Toxicol; 2023 Nov; 38(11):2545-2559. PubMed ID: 37471637
[TBL] [Abstract][Full Text] [Related]
15. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
Min WP; Wei XF
Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-β/Smad2/STAT3/STAT5 pathway.
Sun W; Ma Y; Chen P; Wang D
Mol Med Rep; 2015 May; 11(5):3854-9. PubMed ID: 25586740
[TBL] [Abstract][Full Text] [Related]
18. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.
Zhao Z; Ju Q; Ji J; Li Y; Zhao Y
Front Mol Biosci; 2022; 9():842833. PubMed ID: 35223996
[TBL] [Abstract][Full Text] [Related]
20. BAMBI overexpression together with β-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-β/Smad2/3 pathway.
Wang X; Li M; Hu M; Wei P; Zhu W
Oncol Rep; 2017 May; 37(5):3046-3054. PubMed ID: 28440452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
